Less Ads, More Data, More Tools Register for FREE

Pin to quick picksM P Evans Regulatory News (MPE)

Share Price Information for M P Evans (MPE)

Share Price is delayed by 15 minutes
Get Live Data
1,516.00    -34.00 (-2.19%)
Bid:
1,512.00
Ask:
1,518.00
Spread: 6.00 (0.397%)
Market Cap: £790.81m
MPE Live PriceLast checked at - London Stock Exchange

Intraday M P Evans Share Chart

Transaction in Own Shares

28 Feb 2024 07:00

RNS Number : 6830E
M. P. Evans Group PLC
28 February 2024
Β 

28 February 2024

Β 

Transaction in Own Shares

Β 

M.P. Evans Group PLC (the "Company") announces that it has purchased for cancellation (through Cavendish Capital Markets Limited acting as the Company's broker ("Cavendish")) the following number of its shares of 10p each on the London Stock Exchange.

Date of purchase:

27th February 2024

Number of shares purchased (aggregated volume):

819

Highest price paid per share (pence):

760.5275

Lowest price paid per share (pence):

760.5275

Volume weighted average price paid per share (pence):

760.5275

Β 

Following the purchase and cancellation of these shares, the Company will have 53,231,803 shares in issue. All of the shares have equal voting rights and there are no shares held in treasury. This figure 53,231,803 represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

In accordance with Article 5(1)(b) of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Cavendish as part of the Share Buyback Programme.

Aggregate information:Β 

Venue

Volume-weighted average price (pence per share)

Aggregated volume

AIMX

760.5275

819

Β 

Β Individual transactions:

Β 

Number of shares purchased

Transaction price(pence per share)

Time of transaction

Venue

Β 

819

760.5275

17:01

AIMX

Β 

Enquiries

Β 

M.P. Evans Group PLC

Β 

Peter Hadsley-Chaplin, Chairman Matthew Coulson, Chief executiveLuke Shaw, Chief financial officer

Β 

Β 

Β 

Telephone: +44 (0) 1892 516333

Β 

Β 

Cavendish Capital Markets Limited - Nominated Advisor and Sole Broker

Β 

Matt Goode, George Lawson, Rory Sale - Corporate Finance

Tim Redfern, Harriet Ward - Equity Capital Markets

Β 

Telephone: +44 (0) 20 7220 0500

Β 

Β 

Hudson Sandler - Financial PR

Β 

Charlie Jack, Charlotte Cobb, Francis Kerrigan

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
POSQKOBNOBKDOBB
Date   Source Headline
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:30 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTransaction in Own Shares
28th May 20267:00 amRNSTransaction in Own Shares
26th May 20262:42 pmRNSShare Buyback Programme
20th May 202611:26 amRNSIndonesian commodity exporting
12th May 20262:52 pmRNSAGM Arrangements
1st Apr 20265:40 pmRNS2025 Annual Report
26th Mar 202610:16 amRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSFinal Results 2025
5th Mar 20267:00 amRNSNotice of Results
23rd Jan 20267:00 amRNSDirector/PDMR Shareholding
22nd Jan 20267:00 amRNS2025 Crop and production
16th Jan 20261:05 pmRNSDirector/PDMR Shareholding
6th Jan 20267:00 amRNSDirector/PDMR Shareholding
18th Dec 20257:00 amRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 202512:58 pmRNSPublication of 2024 ESG report
2nd Dec 20251:14 pmRNSCompany update
1st Dec 20257:00 amRNSAppointment of joint broker
10th Nov 20257:00 amRNSStrong pricing during second half of 2025
28th Oct 20255:33 pmRNSHolding(s) in Company
22nd Sep 20253:26 pmRNSAIM Rule 20
15th Sep 20257:00 amRNSHalf-year Report
27th Aug 20257:00 amRNSNotice of interim results & investor presentation
29th Jul 20257:00 amRNSPublication of TCFD report
24th Jul 20257:00 amRNS2025 H1 crop and production
14th Jul 202510:07 amRNSAcquisition
7th Jul 20254:54 pmRNSDirector/PDMR Shareholding
30th Jun 20254:30 pmRNSTotal Voting Rights
25th Jun 202511:18 amRNSIssue of Equity
18th Jun 20257:00 amRNSShare buyback programme
13th Jun 20251:45 pmRNSResult of AGM
13th Jun 20257:00 amRNSAGM Statement
12th Jun 20254:50 pmRNSAppointment to board roles
5th Jun 20257:00 amRNSAGM update
14th May 20257:00 amRNSDirectorate Change
22nd Apr 20255:33 pmRNSDirector/PDMR Shareholding
16th Apr 202511:00 amRNSAcquisition
31st Mar 20254:02 pmRNSPosting of Annual Report
25th Mar 20257:00 amRNSFinal Results
21st Mar 20257:00 amRNSDirector retirement
5th Mar 20257:00 amRNSNotice of Results and investor presentation
20th Jan 20253:05 pmRNSDirector/PDMR Shareholding
20th Jan 20257:00 amRNSCrop and production
2nd Jan 202511:31 amRNSDirector/PDMR Shareholding
2nd Jan 20257:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.